SmartRent reports Q3 EPS (5c), consensus (2c)
Q3 Revenue Performance: SmartRent reported Q3 revenue of $40.51 million, falling short of the consensus estimate of $45.94 million.
Strategic Focus and Market Position: Chairman John Dorman highlighted the company's resilience and strategic focus despite challenges, emphasizing that execution issues are the main concern while the core business model and market potential remain strong.
Trade with 70% Backtested Accuracy
Analyst Views on SMRT
About SMRT
About the author

- Revenue Growth: SmartRent reported total revenue of $38.7 million in Q1 2026, reflecting a 9% year-over-year increase, with SaaS revenue at $15.2 million and hardware revenue at $15.4 million, indicating the company's strategic focus on expanding its IoT market presence and revenue diversification.
- IoT Deployment: The company has deployed IoT units in over 911,000 rental units across the U.S., with expectations to surpass 1 million installations by the first half of 2027, which not only enhances market share but also strengthens customer loyalty and future revenue potential.
- Profitability Outlook: Despite current market headwinds, management reiterated their commitment to achieving positive adjusted EBITDA for the full year, with Q1's seasonal cash flow usage not reflective of annual results, demonstrating confidence in the company's financial health moving forward.
- Sales Team Expansion: SmartRent plans to increase its sales team by 25% over the next three months and add VAR partners, aiming to enhance market penetration and sales capacity to address current market conditions and evolving customer demands.
Market Overview: The article discusses the current state of the market, highlighting trends and key performance indicators for Q1.
Economic Indicators: It emphasizes the importance of various economic indicators that are influencing market movements and investor sentiment.
Sector Performance: The performance of different sectors is analyzed, showcasing which areas are thriving and which are struggling.
Future Outlook: The article concludes with predictions and expectations for the upcoming quarters, considering potential challenges and opportunities.
- Earnings Performance: SmartRent reported a Q1 GAAP EPS of -$0.02, missing expectations by $0.01, indicating challenges in profitability amidst a competitive landscape.
- Revenue Growth: The company achieved revenue of $38.7 million, a 6.4% year-over-year decline, yet it exceeded market expectations by $1.88 million, suggesting a resilient demand despite headwinds.
- Strategic Goals: SmartRent aims for double-digit installed base growth through its Vision 2028 strategy, reflecting the company's confidence in future market expansion opportunities.
- Market Reaction: Although the EPS fell short of expectations, the revenue beat may positively influence investor sentiment, helping the company maintain stability in a highly competitive market.
- Market Expansion Strategy: SmartRent's launch of a Value-Added Reseller (VAR) program aims to address the needs of small and mid-market rental property owners, marking a significant upgrade in its go-to-market model and expected to enhance its penetration in the 40 million unit rental market.
- Partnership Dynamics: SKBM Smart Technology, as the first VAR, will leverage its extensive installation experience and industry relationships to provide essential support for SmartRent, thereby accelerating revenue growth in the small market segment.
- Deployment Advantages: With over 900,000 IoT units deployed on its platform and maintenance solutions supporting 1.2 million units, SmartRent's robust foundation will provide solid backing for the successful implementation of the new program.
- Future Vision: SmartRent's Vision 2028 program focuses on expanding its market-leading installed footprint, and the planned VAR network is expected to drive revenue growth in small and mid-markets, further advancing the vision of smarter living.
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.










